SCHEMBL30424287

SCHEMBL30424287

CC(C)(C)OC(=O)NCc1nn(-c2ccc(OC(F)(F)F)cc2)c2nccc(C(=O)O)c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 6/20 0.56
▸ TEAD4 Q15561 6/20 0.56
▸ TEAD2 Q15562 6/20 0.56
▸ TEAD3 Q99594 6/20 0.56
▸ NR3C1 P04150 3/20 0.41
▸ CNR1 P21554 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ KDM4C Q9H3R0 2/20 0.36
▸ KDM5A P29375 1/20 0.36
▸ KDM5B Q9UGL1 1/20 0.36
▸ PDE2A O00408 1/20 0.36
▸ DHODH Q02127 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KCNQ3 O43525 1/20 0.35
▸ KCNQ2 O43526 1/20 0.35
▸ EPHX2 P34913 2/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ NR1H4 Q96RI1 1/20 0.35
▸ ATR Q13535 1/20 0.35
▸ TRPV1 Q8NER1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25205816 1.00 TEAD1 (0.56) TEAD1TEAD4TEAD2TEAD3NR3C1
SCHEMBL25751652 0.93 TEAD1 (0.56) TEAD1TEAD4TEAD2TEAD3NR3C1
SCHEMBL30424153 0.93 TEAD1 (0.56) TEAD1TEAD4TEAD2TEAD3NR3C1
SCHEMBL25751589 0.91 TEAD1 (0.55) TEAD1TEAD4TEAD2TEAD3NR3C1
SCHEMBL30424418 0.91 TEAD1 (0.55) TEAD1TEAD4TEAD2TEAD3NR3C1
SCHEMBL25751575 0.89 TEAD1 (0.55) TEAD1TEAD4TEAD2TEAD3NR3C1
SCHEMBL30423410 0.89 TEAD1 (0.55) TEAD1TEAD4TEAD2TEAD3NR3C1
SCHEMBL25245319 0.88 TEAD1 (0.59) TEAD1TEAD4TEAD2TEAD3NR3C1
SCHEMBL29266839 0.88 TEAD1 (0.52) TEAD1TEAD4TEAD2TEAD3NR3C1
SCHEMBL30424431 0.87 TEAD1 (0.56) TEAD1TEAD4TEAD2TEAD3NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436957-A1 THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER Genentech, Inc. (US) 2024-10-02 — — EP disclosed
CN-118302411-A Therapeutic indazole compounds and methods of use thereof for the treatment of cancer 基因泰克公司 2024-07-05 — — CN disclosed
WO-2023097195-A1 THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER GENENTECH, INC. (US) 2023-06-01 — — WO disclosed
Send feedback